Overview

Patient Preference Study

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
In this randomized crossover study, patients will receive a single drop of two test articles and assess comfort.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Dorzolamide
Ophthalmic Solutions
Pharmaceutical Solutions
Timolol